These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 605352)

  • 1. Impaired oxidation of antipyrine in stagnant loop rats.
    Aarbakke J
    Scand J Gastroenterol; 1977; 12(8):929-35. PubMed ID: 605352
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation.
    Scavone JM; Greenblatt DJ; LeDuc BW; Blyden GT; Luna BG; Harmatz JS
    Pharmacology; 1990; 40(2):77-84. PubMed ID: 2345775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
    Døssing M; Pilsgaard H; Rasmussen B; Poulsen HE
    Eur J Clin Pharmacol; 1983; 25(2):215-22. PubMed ID: 6628504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
    Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
    Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Abernethy DR; Knüchel M
    Pharmacology; 1984; 28(4):188-95. PubMed ID: 6728897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice.
    Wilson VL; Larson RE; Moldowan MJ
    Chem Biol Interact; 1982 Jun; 40(2):159-68. PubMed ID: 7083391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 10. Spironolactone--a weak enzyme inducer in man.
    Taylor SA; Rawlins MD; Smith SE
    J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipyrine metabolite kinetics in phenobarbital and beta-naphthoflavone-induced rats.
    Rhodes JC; Houston JB
    Drug Metab Dispos; 1983; 11(2):131-6. PubMed ID: 6133717
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of hepatic drug metabolism in patients with Budd-Chiari syndrome.
    Narang AP; Datta DV; Mathur VS
    Indian J Med Res; 1982 Apr; 75():567-73. PubMed ID: 7106896
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: The relationships between liver volume and the disposition of antipyrine and indocyanine green before and after phenobarbitone treatment.
    Branch RA; Halliwell M; Jackson L; Roberts CJ
    Br J Pharmacol; 1975 Oct; 55(2):263P. PubMed ID: 1201403
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple oral doses of diazepam, oxazepam and phenobarbital to dogs--behavioural effects and correlation with antipyrine half-life.
    Albanus L; Jönsson M; Sparf B
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40 Suppl 1(1):63-9. PubMed ID: 300543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sources of interindividual variations in acetaminophen and antipyrine metabolism.
    Nash RM; Stein L; Penno MB; Passananti GT; Vesell ES
    Clin Pharmacol Ther; 1984 Oct; 36(4):417-30. PubMed ID: 6541104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diethyl ether influence on the metabolism of antipyrine, paracetamol and sulphanilamide in isolated rat hepatocytes.
    Aune H; Olsen H; Mørland J
    Br J Anaesth; 1981 Jun; 53(6):621-6. PubMed ID: 7248125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.